hannahwoolley

126 POSTS 0 COMMENTS

VisONE system for heart failure implanted for first time

VisCardia has announced the first implant of its VisONE implantable system for heart failure, and the commencement of its VisONE Heart Failure pilot study...

The rise of smartphones and wearables for AF detection: WATCH-AF and...

How to best combine optimal screening and diagnosis for atrial fibrillation (AF) has long been a challenge. At European Heart Rhythm Association Congress (EHRA;...

Patients undergoing lead extraction are more likely to survive superior vena...

A study looking at patients undergoing lead extraction found that they were more likely to survive superior vena cava tears when treatment included the...

Cybersecurity safety communications for implantable cardiac devices: Year in review

Cyber security has become a hot topic in recent years. Leslie Saxon writes in Cardiac Rhythm News about the cybersecurity risks for implantable cardiac...

Call for paradigm shift to CPR competency to save 50,000 additional...

Heart imaging has been successfully used to predict the benefit or futility of catheter ablation. The investigators described their findings in the Journal of the American College of Cardiology: Cardiovascular Imaging.
The American Heart Association (Association) and Laerdal Medical (Laerdal) are furthering their decades-long alliance to deliver a new standard of resuscitation quality and patient...

Medi-Lynx receive FDA 510(K) clearance for PocketECG CRS mobile cardiac rehabilitation...

MEDICALgorithmics and US subsidiary Medi-Lynx Cardiac Monitoring L.L.C., have announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the...

Clinical trial to evaluate ECG belt for optimising heart failure therapy...

Medtronic has announced the first enrolments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool...

Stroke – the need for interdisciplinary concepts

The link between cardiac diseases and stroke is well known and reported. Wolfram Döhner writes in Cardiac Rhythm News about the needs for interdisciplinary...

His bundle pacing is associated with reduced morbidity and mortality when...

His bundle pacing was successful in 92% of patients and the primary endpoint of death, heart failure hospitalisation or upgrade to biventricular pacing was...

Thoracoscopic ablation and left atrial appendage excision found to be superior...

Symptomatic atrial fibrillation (AF) patients with previous failed catheter ablation or structural changes associated with higher recurrence of AF could benefit from thoracoscopic ablation...

Bardy Diagnostics announces additional growth capital funding

Bardy Diagnostics has announced that it has raised additional growth capital from its existing equity investors, including SV Health Investors ("SVHI"), Health Enterprise Partners,...

Continuous homebased ECG monitoring results in a significantly higher rate of...

The mHealth Screening To Prevent Strokes (mSToPS) randomised clinical trial showed that home-based wearable electrocardiogram (ECG) sensor patch monitoring, compared with delayed monitoring, resulted in...

How gender impacts pathophysiology treatment of cardiac arrhythmia

Differences between men and women mean that outcomes after cardiac events can differ between the sexes. Cecilia Linde writes in Cardiac Rhythm News about...

Expanded indication for pacing lead for His bundle site stimulation

A press release has announced US Food and Drug Administration (FDA) labeling expansion for the Medtronic SelectSecure MRI SureScan Model 3830 cardiac pacing lead...

HeartWare HVAD system receives US FDA approval

Medtronic has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist...

Long-term survival worse for black survivors of in-hospital cardiac arrest

Black people who survive cardiac arrest during hospitalisation have lower odds of long-term survival compared with similar white survivors, according to new research published...

Leadless pacemaker patients less likely to experience complications major US study...

Research finds use of smaller, self-contained devices reduced complications for up to 18 months compared with conventional designs The findings of the research, led by...

US patent issued for implantable LVAD with wave membrane technology

CorWave obtained patent no. US 9,968,720 B2 on May 15, 2018 from the United States Patent and Trademark Office. Titled “Implantable pump system having an...

LVAD technology improves, providing better, longer-term outcomes

This article was sponsored by Abbott. Left ventricular assist devices (LVAD) are mechanical pumps that are implanted inside a person's chest to help their weakened...

Boston Scientific to acquire Cryterion Medical

As part of its plan to expand it atrial fibrillation ablation therapy offering, Boston Scientific Corporation has announced a definitive agreement to acquire Cryterion...

Researchers design novel micropacemaker

Investigators at Children's Hospital Los Angeles and the University of Southern California, Los Angeles, USA, have demonstrated the feasibility of implanting a micropacemaker system in the...

COMPASS trial suggests that combination of rivaroxaban and aspirin lowers the...

By Hannah Woolley Findings from the Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS) trial suggest that the...

Analysis of the BRUISE CONTROL 1 and 2 trials shows no...

By Hannah Woolley In a multivariate analysis including both BRUISE CONTROL 1 and BRUISE CONTROL 2 patients and adjusted for antiplatelet use, there was no...

Risks of long dwell lead extraction

By Hannah Woolley Longer dwell times are related to higher rates of complication during lead extraction. There have been various studies looking at the risk...

Autonomic modulation for refractory ventricular arrhythmias: Going beyond the heart

Patients with scar-related ventricular tachycardia (VT) do not often achieve a cure. Jason S Bradfield and Kalyanam Shivkumar write in Cardiac Rhythm News about...

HeartSciences named “Start-Up to Watch”

HeartSciences has announced that it has been highlighted as a “Start-Up to Watch” in the June 8, 2018 issue of the MedTech Strategist. The...

Wearable defibrillators may be an alternative to surgically implanted device for...

Wearable cardioverter defibrillators – vest-like devices that deliver electric shocks to interrupt a dangerous heart rhythm – may be a safe and effective alternative...

Obese people with atrial fibrillation can reduce or reverse the effects...

Published in the heart journal Europace, the researchers found that a 10% loss in weight along with management of associated risk factors, can reverse the...

Framework for the use of wearable medical devices in regulatory clinical...

New guidance regarding the selection and evaluation of wearable devices for use in regulatory trials and to support labelling claims has been published in...

US FDA issues draft guidances for recommended premarket testing and labelling...

The US Food and Drug Administration (FDA) released the following two draft guidance documents: These guidance documents provide industry and FDA staff with recommendations on...

Phase I study initiated to evaluate a new precision oral anticoagulant...

The first-in-human phase I trial will take place in Australia for Verseon’s PROAC (PRecision Oral AntiCoagulant) VE-1902, which has successfully completed regulatory toxicology studies...

Binge drinking affects heart rhythm

A new study has found that the more alcohol you drink, the higher your heart rate gets. These finding were presented at European Heart...

Ultralow temperature ablation: Results from the Cryocure I and Cryocure II...

The trials found that ultralow temperature cryoablation is feasible and shows excellent safety and efficacy. The clinical outcomes for flutter ablation show a 94%...

Algorithm can accurately detect atrial fibrillation and differentiate from sinus rhythm

The algorithm (Kardiaband, AliveCor) for atrial fibrillation (AF) detection, when supported by physician review can accurately differentiate AF from sinus rhythm (SR). This technology...

More than US$28 million awarded for new atrial fibrillation research centres...

The American Heart Association has announced research grants totalling more than US$28 million to the scientific teams that will create a new research network...

BIOTRONIK opens education and innovation centre in Tokyo

BIOTRONIK have announced the opening of its Education and Innovation Centre in Ebisu, Tokyo, Japan. The centre will provide the latest educational programs and...

Zenicor selected as supplier to the world’s largest screening programme for...

Zenicor Medical Systems AB has been selected as sole supplier for a screening programme in the UK for atrial fibrillation. The screening programme is...

Philips expands its cardiac rhythm portfolio with the acquisition of EPD...

Royal Philips has announced that it has signed an agreement to acquire EPD Solutions. EPD’s cardiac imaging and navigation system helps electrophysiologists navigate the...

FDA classifies HeartWare HVAD systems unexpected power source switching as Class...

The United States Food and Drug Administration (FDA) has classified Medtronic recent voluntary urgent field action related to the HeartWare HVAD System unexpected power...

Surgical treatment of atrial fibrillation results in higher complication rates when...

The total procedure-related complications after surgical minimally invasive pulmonary vein isolations (MIPI) were higher; this was mainly due to more major complications. During a...

European Sudden Cardiac Arrest network will look at gender-based prevention and...

Researchers will use a European network of 90,000 patients, including 20,000 DNA samples, to look at different approaches for prevention and treatment of sudden...

Apixaban is a safe alternative to warfarin during catheter ablation of...

Apixaban and warfarin are equally safe during catheter ablation of atrial fibrillation, according to results of the AXAFA-AFNET 5 (Anticoagulation using the direct factor...

Left atrial function measures predict atrial fibrillation

The Copenhagen City Heart Study set out to investigate whether left atrial (LA) functional measures predict atrial fibrillation (AF) in the general population. They...

Point-of-care testing of coagulation in patients treated with edoxaban

The first systematic evaluation of coagulation point-of-care testing in edoxaban treated patients has been carried out. The results were presented by Florian Härtig, University...

REAFFIRM: An interim analysis

The interim results of the REAFFIRM (Randomised Evaluation of Atrial Fibrillation treatment with Focal Impulse and Rotor Modulation guided procedures) trial showed there was...

 Octreotide enables left atrial appendage closure in AF patients with GI...

Octreotide therapy has the potential to offer atrial fibrillation (AF) patients with arteriovenous malformations (AVM) related gastrointestinal (GI) bleeding another treatment option. It is...

Real-time lesion formation and gap detection during ablation: DURABLE-I follow-up

One-year results from the Dielectric Unravveling of RAdiofrequency ABLation Effectiveness (DURABLE-I) clinical trial have shown that the KODEX (Navix International Limited) system help to...

Atrial fibrillation detection with smartwatch or smartphone camera achieved >95% accuracy

The results of the WATCH AF trial, the world’s first international, prospective and double-blinded clinical trial (ClinicalTrials.gov ID: NCT02956343) evaluating the accuracy of a...

Dhanunjaya Lakkireddy

Dhanunjaya Lakkireddy is executive medical director at The Kansas City Heart Rhythm Institute at HCA Midwest Health, Kansas, USA. He holds the title Professor...

Luigi Di Biase

Luigi Di Biase is a prominent electrophysiologist, section head of Electrophysiology, director of Arrhythmia Services, and professor of Medicine (Cardiology) at the Albert Einstein...

Cardiac Rhythm News Issue 41 – May 2018 EU edition

Highlights: Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and may have a positive effect on cognitive function Stroke...

Cardiac Rhythm News Issue 41 – May 2018 US edition

Highlights: Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and may have a positive effect on cognitive function Stroke...

Boston Scientific launches the HeartLogic heart failure diagnostic in Europe

Boston Scientific Europe has announced the launch of the HeartLogic Heart Failure Diagnostic in Europe. With this launch, the first and only diagnostic tool...

RHYTHM study published revealing link between total AF burden and stroke...

iRhythm Technologies has announced results of a study which utilised Zio by iRhythm, an extended continuous cardiac monitoring system, to provide a comprehensive picture...

Study confirms feasibility of new extravascular approach to ICD therapy

Results from a research study demonstrating the feasibility of a novel approach to delivering pacing and defibrillation therapy in which a lead is placed...

AdaptivCRT Algorithm shown to be associated with improved patient survival

Study results show that the AdaptivCRT algorithm is associated with improved patient survival. The real-world, prospective registry of 1,835 patients, use of the AdaptivCRT...

Real-world data demonstrates success of SMART Pass on the S-ICD System

Results from an analysis of the LATITUDE database which evaluated the successful reduction of inappropriate shocks using the SMART Pass sensing filter in patients...

Implantable cardiac monitor gets FDA market approval

The AngelMed Guardian System is an implantable cardiac monitor intended to detect and alert patients of a potential heart attack. The Guardian System consists...

New real-world study finds long-term rivaroxaban use resulted in fewer strokes...

Two-year results show rivaroxaban was associated with reduced stroke and systemic embolism versus warfarin, without altering risk of major bleeding. The study evaluated efficacy...

HeartMate 3 left ventricular assist system: Class I recall

The US FDA has issued a class I recall due to a malfunction in the device’s outflow graft assembly that may cause the outflow...

First cardiac procedure using the AcQMap System by Acutus Medical ...

 Acutus Medical has announced that the AcQMap High Resolution Imaging and Mapping System has been utilised for the first time in US patients. The...

BodyGuardian Mini, the smallest, reusable, waterproof cardiac Holter monitor launched

Preventice Solutions has announced the launch of the BodyGuardian Mini, the smallest, reusable long-term Holter technology available for cardiac monitoring. The new, compactly designed...

FDA approval of the next-generation HeartLight Excalibur balloon designed for the...

The US Food and Drug Administration (FDA) has granted approval for the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of paroxysmal atrial...

Sheath designed to reduce radiation exposure and improve ablation procedure efficiency...

The CARTO VIZIGO Bi-directional Guiding Sheath is now available in the United States. This is the first commercially available steerable guiding sheath that can be...

Stereotaxis and Acutus medical announce strategic collaboration

Stereotaxis has announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic Navigation System and the Acutus Medical AcQMap High Resolution Imaging and Mapping...

How much should we screen?

At the AF Symposium (11–13 January 2018, Orlando, USA) John Camm, St George’s University of London and Imperial College, London, UK, looked at the...

HAVOC: new score developed to identify AF patients at higher risk...

The HAVOC score was developed following the CRYSTAL-AF study, to see if there was an easier way to identify which patients with atrial fibrillation...

Factor XI inhibitors: a new class of anticoagulants that may reduce...

More patients than ever before are being given NOACs due to their relative stability and safety, but the risk of gastrointestinal bleeding with NOACs...

DEEP-guided ablation may enable better treatment of ventricular tachycardia

Results from a multicentre study of catheter ablation guided by DEEP (decrement-evoke potential) mapping show that using DEEP mapping meant that ablation was successful...

Cardiac devices could be at risk of hacking

Medical devices, including cardiovascular implantable electronic devices could be at risk for hacking. In a paper published in the Journal of the American College...

Activation patterns at termination sites reveal stable rotation in human persistent...

Local activation mapping at sites of termination of persistent atrial fibrillations (AF) shows repetitive patterns including rotational or focal activity reports a study in...

Catheter ablation for atrial fibrillation:Lessons and developments from 2017

2017 was a year of big results for catheter ablation, continuing the procedure’s steady rise in atrial fibrillation (AF) management. Mark O’Neill, consultant cardiologist...

Nassir Marrouche

Nassir Marrouche is a prominent electrophysiologist, executive director of the Comprehensive Arrhythmia Research and Management (CARMA) Centre at the University of Utah in Salt...

Cardiac Rhythm News Issue 40 – March 2018

Highlights: Real-time lesion formation and gap detection during ablation: DURABLE-I follow-up Octreotide enables left atrial appendage closure in AF patients with GI bleeding M...

LivaNova completes US$190M sale of cardiac rhythm unit

LivaNova cardiac rhythm management
LivaNova has finalised the US$190 million sale of its cardiac rhythm unit to MicroPort Scientific. The final terms of the deal commit LivaNova to paying...

Battery performance alert and cybersecurity firmware updates for certain Abbott implantable...

The US FDA has approved a firmware update that is now available and is intended as a corrective action (recall), to reduce the risk...

HeartSciences announces publication of clinical study results

A medical device company has announced the results of a clinical study serially conducted at The Icahn School of Medicine, Mount Sinai Hospital, New...

Murj expands offering to manage in-office cardiac device monitoring

Murj, a healthcare technology company focused on transforming implantable cardiac device management, has announced the availability of OnSite— the industry’s first cloud-based workflow solution...

Socioeconomic status and geographic region affect patient access to ICDs in...

There is a disparity between indications for and utilisation of implantable cardioverter defibrillators (ICDs) in Asian patients with heart failure, a recent study finds....

One in five NBA players have abnormal ECGs

A recent study by Marc P Waase (Columbia University Medical Center, New York, USA) et al published in the Journal of the American Medical...

New guidelines promote safety for patients on antithrombotic drugs undergoing anaesthesia...

Patient safety is the focus of newly published updates to consensus statements that address the use of antithrombotic drugs by individuals who may require...

Treating sleep apnoea in pacemaker patients improves AF therapy

This video has been sponsored by LivaNova. Sleep apnoea is a major chronic disease that can have cardiovascular consequences. Around 40–50% of people with atrial...

Boston Scientific announces acquisition of Securus Medical Group

Boston Scientific have announced the acquisition of Securus Medical Group, a privately-held company that has developed a thermal monitoring system for the continuous measurement...

Clinical wearables and cardiac health apps: Trends and challenges

Cardiac health apps and wearable clinical technology is on the rise, along with remote monitoring and wireless connection functionality in implantable cardiac devices. While...

Successful ablation for ventricular tachycardia associated with markedly reduced mortality in...

    Wendy Tzou (University of Colorado School of Medicine, Denver, USA) and colleagues at the International Ventricular Tachycardia Ablation Center Collaborative group (IVTCC) published two...

Brain MRI scans can inform the choice between OACs and LAA...

M Edip Gurol is a stroke neurologist with particular expertise in the care of patients at high risk for ischaemic (blockage type) strokes and...

New analyses show that AdaptivCRT algorithm reduces AF episodes in patients

Two real-world analyses featuring the AdaptivCRT algorithm reinforce that its use is linked to a reduction in atrial fibrillation (AF) episodes, as well as...

Study shows positive results with cryoballoon for patients with persistent atrial...

One-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance Cryoballoon to isolate the pulmonary veins in patients with symptomatic...

Study finds the heart can terminate atrial fibrillation itself after local...

The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according...

Stroke prevention drugs may help reduce dementia risk for atrial fibrillation...

Patients with atrial fibrillation could reduce the risk of dementia by taking stroke prevention medications, according to recommendations published online in EP Europace1, a...

Clinical trial data further demonstrate safety and effectiveness of RHYTHMIA mapping...

Data from the TRUE-HD study has been announced during a late-breaking clinical trial session at the annual congress of the European Heart Rhythm Association...

Obesity may make subcutaneous implantable cardioverter-defibrillators less effective during testing

Obese patients are at a higher risk of failed first subcutaneous implantable cardioverter-defibrillator (S-ICD) shocks during defibrillation testing. This is what a group from...

IMPLANTED suggests link between physical activity and atrial arrhythmias in heart...

Low level of daily physical activity was associated with a higher risk of atrial arrhythmias in heart failure patients with implantable devices. A low...

First patient treated in SHINE study of multi-electrode radiofrequency balloon catheter

The first patient has been enrolled and treated in the SHINE clinical study in Europe. The multicentre study aims to evaluate balloon ablation catheter...

Interim results from ongoing ANNEXA-4 study of Factor Xa inhibitor reversal...

Interim data from 228 patients (of which 132 were adjudicated for efficacy) showed that AndexXa rapidly and significantly reversed anti-Factor Xa activity (the anticoagulant...

New long-term data show improved survival and lower rates of stroke...

New late-breaking clinical trial data from the MOMENTUM 3 clinical study shows overall survival of 83% at 2-years and marked improvement in clinical outcomes for...

EBR Systems initiates global trial of world’s only wireless CRT pacing...

EBR Systems has announced enrollment of the first patients in the global SOLVE-CRT (Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronisation Therapy) clinical...

Zio by iRhythm shown to improve detection of previously undiagnosed atrial...

iRhythm Technologies has announced primary results of the mHealth Screening to Prevent Strokes (mSToPS) study that evaluated detection of silent atrial fibrillation (AF) in...

Canon Medical Systems Corporation acquires Fysicon

Fysicon has announced that it has been acquired by Canon Medical Systems Corporation (Otawara, Japan).   Linda Elberse, chief executive officer of Fysicon said, "Being...

US Patent Office allows AblaCor five ablation catheter-anchoring patents

AblaCor medical corporation has announced that it has received a notice of allowance from the United States Patent & Trademark Office on five additional patents for...

Cardiac arrest survival increases with bystanders use of automated external defibrillator

Survival from cardiac arrest doubled when a bystander stepped in to apply an automated external defibrillator (AED) before emergency responders arrived, according to new...

CardioFocus announces initiation of HeartLight X3 clinical evaluation

CardioFocus have announced the initiation of a clinical evaluation of the new HeartLight X3 system for the treatment of AF. Building upon the advanced features of the...

Medtronic: class I recall- manufacturing error preventing electrical shock delivery

Medtronic is recalling certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy defibrillators (CRT-Ds) due to a defect in the manufacturing process.  This defect...

EPD obtains European regulatory approval for its cardiac mapping and navigation...

EPD’s Cardiac Mapping and Navigation System  has received CE mark approval.  The system helps electrophysiologists navigate the heart by generating an accurate 3D map,...

AtriCure launches the AtriClip FLEX•V device in the United States

AtriCure, Inc., a leading innovator in treatments for atrial fibrillation and left atrial appendage management, has announced that it has launched the AtriClip FLEX•V...

Clarithromycin (Biaxin): potential increased risk of heart problems or death in...

The FDA is advising caution before prescribing the antibiotic clarithromycin (Biaxin) to patients with heart disease because of a potential increased risk of heart...

Short-term DAPT is feasible for patients undergoing percutaneous LAA closure

Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and others report in EuroIntervention that a strategy of six weeks’ duration of dual antiplatelet therapy (DAPT)...

New-onset atrial fibrillation after CABG significantly increases the risk of death...

New data from the EXCEL trial, which found that percutaneous coronary intervention (PCI) was non-inferior to coronary artery bypass grafting (CABG) at three years...

Cardiva Medical brings total financing round to US$41 million

Cardiva Medical, an innovator in the field of vascular closure, has announced that the company has closed on US$11 million in additional financing –...

LEADLESS: Miniature pacemaker effective at three years, but battery to be...

A miniature leadless pacemaker was safe and effective at three years in the first-in-human LEADLESS study, according to a research letter published in Circulation. However,...

African Americans with atrial fibrillation at significantly higher risk of stroke

African Americans with atrial fibrillation (AF) have a significantly higher risk of stroke than Caucasians with the condition, according to new research published in HeartRhythm by...

Association found between left atrial appendage closure and readmission for thromboembolism

A collaborative study, has found that older patients with atrial fibrillation (AF) undergoing cardiac surgery accompanied with surgical left atrial appendage closure had a...

New data demonstrates >90% year 1 success rate for radiofrequency ablation...

Biosense Webster, a Division of Johnson & Johnson Medical NV/SA, and a leader in the diagnosis and treatment of cardiac arrhythmias, recently presented new...

Biomarker predicts success of atrial fibrillation treatment

Heart imaging has been successfully used to predict the benefit or futility of catheter ablation. The investigators described their findings in the Journal of the American College of Cardiology: Cardiovascular Imaging.
Written by Hannah Woolley, Cardiac Rhythm News Editor Heart imaging has been successfully used to predict the benefit or futility of catheter ablation. The investigators...

Class I recall: HeartStart MRx defibrillator by Philips Electronics

Philips is recalling the HeartStart MRx defibrillator due to a defect in the device's gas discharge tube. The gas discharge tube has micro cracks...

Warfarin linked to lower rate of cancer, particularly for atrial fibrillation...

A recent study by Gry Haaland (University of Bergen, Bergen, Norway) et al published in the Journal of the American Association of Medicine (JAMA):...

Acesion Pharma receives approval for Phase I study in atrial fibrillation

Acesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, announced it has received approval to...

Cardiac Rhythm News Issue 39 – January 2018

Highlights: Less bleeding in ablation with interrupted dabigatran compared to uninterrupted warfarin Successful ablation for ventricular tachycardia associated with markedly reduced mortality in advanced heart failure patients Natalia Trayanova: Imaging-based...

Respicardia announces first U.S. commercial case with the remedē system

  Respicardia, Inc., a medical technology company developing therapies that improve cardiovascular health, have announced the first U.S. commercial case using the remedē system to...

Imaging-based simulations for predicting sudden death and guiding ablation

Natalia Trayanova envisions the future of cardiology and electrophysiology advancing through personalised medicine and computational simulations. Trayanova is the director of the Computational Cardiology Lab at Johns Hopkins University (Baltimore, USA), as well as the Murray B Sachs professor in the Department of Biomedical Engineering and the university’s Institute for Computational Medicine. In this commentary, she discusses her research and the potentials of combining clinical imaging with computational modelling to create a unique virtual heart–one for every patient
Natalia Trayanova envisions the future of cardiology and electrophysiology advancing through personalised medicine and computational simulations. Trayanova is the director of the Computational Cardiology...

Activation patterns at termination sites reveal stable rotation in human persistent...

Local activation mapping at sites of termination of persistent atrial fibrillations (AF) shows repetitive patterns including rotational or focal activity reports a study in...

Results of CASTLE-AF trial published: catheter ablation better than conventional drug...

The results of the CASTLE-AF study, published today in the New England Journal of Medicine, show that patients treated with radiofrequency catheter ablation rather than...

Cardiostim will not be held in 2018

Following EHRA’s decision to hold its own annual congress in March and the difficulty for the industry to financially support Cardiostim as well as...

Boston Scientific announces investment and acquisition option agreement with Millipede, Inc.

  Boston Scientific Corporation today announced it has closed an investment and entered into an acquisition option agreement with Millipede, Inc., a privately-held company that has developed...

Less bleeding in ablation with interrupted dabigatran compared to uninterrupted warfarin 

The results of ABRIDGE-J, a Japanese multicentre randomised study on minimally interrupted dabigatran vs. uninterrupted warfarin for catheter ablation, were presented during a late-breaking...

Imricor announces completion of enrolment for MRI-guided ablations clinical study

imricor
Imricor Medical Systems announced today the completion of enrolment for the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...